{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:10:45Z","timestamp":1791835845257,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009448","name":"Universit\u00e0 degli Studi della Campania Luigi Vanvitelli","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009448","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Growing interest has been accumulated in the definition of worsening effects of diabetes in the cardiovascular system. This is associated with epidemiological data regarding the high incidence of heart failure (HF) in diabetic patients. To investigate the detrimental effects both of hyperglycemia and insulin resistance, a lot of preclinical models were developed. However, the evidence of pathogenic and histological alterations of the so-called diabetic cardiomyopathy (DCM) is still poorly understood in humans. Here, we provide a stringent literature analysis to investigate unique data regarding human DCM. This approach established that lipotoxic-related events might play a central role in the initiation and progression of human DCM. The major limitation in the acquisition of human data is due to the fact of heart specimen availability. Postmortem analysis revealed the end stage of the disease; thus, we need to gain knowledge on the pathogenic events from the early stages until cardiac fibrosis underlying the end-stage HF.<\/jats:p>","DOI":"10.1007\/s00592-021-01705-x","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T17:03:13Z","timestamp":1617210193000},"page":"983-988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Evidence for human diabetic cardiomyopathy"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3960-9270","authenticated-orcid":false,"given":"Raffaele","family":"Marfella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestino","family":"Sardu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelsomina","family":"Mansueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Paolisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"issue":"24","key":"1705_CR1","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"CC Low Wang","year":"2016","unstructured":"Low Wang CC, Hess CN, Hiatt WR, Goldfine AB (2016) Clinical update: cardiovascular disease in diabetes mellitus. Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus \u2013 mechanisms, management, and clinical considerations. Circulation 133(24):2459\u2013502. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022194","journal-title":"Circulation"},{"issue":"11","key":"1705_CR2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/eci.12673","volume":"46","author":"M Mizamtsidi","year":"2016","unstructured":"Mizamtsidi M, Paschou SA, Grapsa J, Vryonidou A (2016) Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes? Eur J Clin Invest 46(11):947\u2013953. https:\/\/doi.org\/10.1111\/eci.12673","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"1705_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR (2018) Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res 122(4):624\u2013638. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311586","journal-title":"Circ Res"},{"key":"1705_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595\u2013602","journal-title":"Am J Cardiol"},{"key":"1705_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29\u201334","journal-title":"Am J Cardiol"},{"key":"1705_CR6","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B et al (2013) American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147\u2013e239. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.019","journal-title":"J Am Coll Cardiol"},{"key":"1705_CR7","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryden","year":"2013","unstructured":"Ryden L, Grant PJ, Anker SD et al (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34:3035\u20133087. https:\/\/doi.org\/10.1093\/eurheartj\/eht108","journal-title":"Eur Heart J"},{"issue":"3","key":"1705_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","volume":"71","author":"TH Marwick","year":"2018","unstructured":"Marwick TH, Ritchie R, Shaw JE, Kaye D (2018) Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy. J Am Coll Cardiol 71(3):339\u2013351. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.019","journal-title":"J Am Coll Cardiol"},{"issue":"27","key":"1705_CR9","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","volume":"36","author":"PM Seferovi\u0107","year":"2015","unstructured":"Seferovi\u0107 PM, Paulus WJ (2015) Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J 36(27):1718\u20131727. https:\/\/doi.org\/10.1093\/eurheartj\/ehv134","journal-title":"Eur Heart J"},{"key":"1705_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93:137\u2013188","journal-title":"Physiol Rev"},{"key":"1705_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocrine Rev 25:543\u2013567","journal-title":"Endocrine Rev"},{"key":"1705_CR12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/euhj.1998.1057","volume":"19","author":"European Study Group on Diastolic Heart Failure","year":"1998","unstructured":"European Study Group on Diastolic Heart Failure (1998) How to diagnose diastolic heart failure. Eur Heart J 19:990\u20131003","journal-title":"Eur Heart J"},{"issue":"14","key":"1705_CR13","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.jacc.2017.07.792","volume":"70","author":"L Ernande","year":"2017","unstructured":"Ernande L, Audureau E, Jellis CL et al (2017) Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus. J Am Coll Cardiol 70(14):1704\u20131716. https:\/\/doi.org\/10.1016\/j.jacc.2017.07.792","journal-title":"J Am Coll Cardiol"},{"key":"1705_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00059-011-3429-4","volume":"36","author":"B Maisch","year":"2011","unstructured":"Maisch B, Alter P, Pankuweit S (2011) Diabetic cardiomyopathy \u2013 fact or fiction? Herz 36:102\u2013115","journal-title":"Herz"},{"key":"1705_CR15","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCHEARTFAILURE.111.966366","volume":"5","author":"SM Dunlay","year":"2012","unstructured":"Dunlay SM, Roger VL, Weston SA, Jiang R, Redfield MM (2012) Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail 5:720\u2013726","journal-title":"Circ Heart Fail"},{"key":"1705_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.110.937821","volume":"122","author":"S Cheng","year":"2010","unstructured":"Cheng S, Xanthakis V, Sullivan LM et al (2010) Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation 122:570\u2013578","journal-title":"Circulation"},{"key":"1705_CR17","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.106.659763","volume":"115","author":"CS Lam","year":"2007","unstructured":"Lam CS, Roger VL, Rodeheffer RJ et al (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County. Circulation 115:1982\u20131990","journal-title":"Circulation"},{"key":"1705_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschoepe C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263\u2013271","journal-title":"J Am Coll Cardiol"},{"key":"1705_CR19","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","volume":"26","author":"AG Bertoni","year":"2003","unstructured":"Bertoni AG, Tsai A, Kasper EK, Brancati FL (2003) Diabetes and idiopathic cardiomyopathy. A nationwide case-control study Diabetes Care 26:2791\u20132795","journal-title":"A nationwide case-control study Diabetes Care"},{"key":"1705_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","volume":"117","author":"L VanHeerebeek","year":"2008","unstructured":"VanHeerebeek L, Hamdani N, Handoko L et al (2008) Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation endproducts and myocyte resting tension. Circulation 117:43\u201351","journal-title":"Circulation"},{"issue":"2","key":"1705_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","volume":"18","author":"T Miki","year":"2013","unstructured":"Miki T, Yuda S, Kouzu H, Miura T (2013) Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev 18(2):149\u2013166. https:\/\/doi.org\/10.1007\/s10741-012-9313-3","journal-title":"Heart Fail Rev"},{"issue":"19","key":"1705_CR22","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","volume":"101","author":"RB Devereux","year":"2000","unstructured":"Devereux RB, Roman MJ, Paranicas M, O\u2019Grady MJ, Lee ET, Welty TK (2000) Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 101(19):2271\u20136","journal-title":"Circulation"},{"issue":"3","key":"1705_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/CIRCIMAGING.109.911438","volume":"3","author":"RS Velagaleti","year":"2010","unstructured":"Velagaleti RS, Gona P, Chuang ML et al (2010) Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging 3(3):257\u201363. https:\/\/doi.org\/10.1161\/CIRCIMAGING.109.911438","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"1705_CR24","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.2337\/dc11-0191","volume":"34","author":"M De Marco","year":"2011","unstructured":"De Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Calhoun D et al (2011) Cardiac geometry and function in diabetic or prediabetic adolescents and young adults. Diabetes Care 34(10):2300\u20132305","journal-title":"Diabetes Care"},{"key":"1705_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/0735-1097(92)90318-H","volume":"19","author":"TJ Regan","year":"1992","unstructured":"Regan TJ, Weisse AB (1992) Diabetic cardiomyopathy. J Am Coll Cardiol 19:1165\u20131166","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1705_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/0975-3583.89805","volume":"2","author":"VC Patil","year":"2011","unstructured":"Patil VC, Patil HV, Shah KB, Vasani JD, Shetty P (2011) Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function. J Cardiovasc Dis Res 2(4):213\u2013222. https:\/\/doi.org\/10.4103\/0975-3583.89805","journal-title":"J Cardiovasc Dis Res"},{"issue":"6","key":"1705_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00125-010-1682-3","volume":"53","author":"H von Bibra","year":"2010","unstructured":"von Bibra H, St John Sutton M (2010) Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia 53(6):1033\u201345. https:\/\/doi.org\/10.1007\/s00125-010-1682-3","journal-title":"Diabetologia"},{"key":"1705_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.104.481465","volume":"113","author":"GP Aurigemma","year":"2006","unstructured":"Aurigemma GP, Zile MR, Gaasch WH (2006) Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function. Circulation 113:296\u2013304","journal-title":"Circulation"},{"key":"1705_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR (2016) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12:144\u2013153. https:\/\/doi.org\/10.1038\/nrendo.2015.216","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"1705_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jacc.2014.05.030","volume":"64","author":"BR Lindman","year":"2014","unstructured":"Lindman BR, D\u00e1vila-Rom\u00e1n VG, Mann DL et al (2014) Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study. J Am Coll Cardiol 64(6):541\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2014.05.030","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1705_CR31","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED (2014) Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57(4):660\u2013671. https:\/\/doi.org\/10.1007\/s00125-014-3171-6","journal-title":"Diabetologia"},{"key":"1705_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10741-013-9377-8","volume":"19","author":"M Isfort","year":"2014","unstructured":"Isfort M, Stevens SC, Schaffer S, Jong CJ, Wold LE (2014) Metabolic dysfunction in diabetic cardiomyopathy. Heart Fail Rev 19:35\u201348","journal-title":"Heart Fail Rev"},{"key":"1705_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10741-013-9388-5","volume":"19","author":"E Adeghate","year":"2014","unstructured":"Adeghate E, Singh J (2014) Structural changes in the myocardium during diabetes-induced cardiomyopathy. Heart Fail Rev 19:15\u201323","journal-title":"Heart Fail Rev"},{"key":"1705_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.echo.2003.08.012","volume":"17","author":"SJ Khouri","year":"2004","unstructured":"Khouri SJ, Maly GT, Suh DD, Walsh TE (2004) A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 17:290\u2013297","journal-title":"J Am Soc Echocardiogr"},{"key":"1705_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10741-006-0232-z","volume":"11","author":"I Gottlieb","year":"2006","unstructured":"Gottlieb I, Macedo R, Bluemke DA, Lima JA (2006) Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives. Heart Fail Rev 11:313\u2013323","journal-title":"Heart Fail Rev"},{"issue":"37","key":"1705_CR36","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"1988","author":"GM Reaven","year":"1988","unstructured":"Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 1988(37):1595\u20131607","journal-title":"Diabetes"},{"key":"1705_CR37","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI119015","volume":"98","author":"G Paternostro","year":"1996","unstructured":"Paternostro G, Camici PG, Lammerstma AA et al (1996) Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease - a study with positron emission tomography. J Clin Invest 98:2094\u20132099","journal-title":"J Clin Invest"},{"key":"1705_CR38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","volume":"46","author":"W Doehner","year":"2005","unstructured":"Doehner W, Rauchhaus M, Ponikowski P et al (2005) Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 46:1019\u20131026","journal-title":"J Am Coll Cardiol"},{"key":"1705_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jama.294.3.334","volume":"294","author":"E Ingelsson","year":"2005","unstructured":"Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L (2005) Insulin resistance and risk of congestive heart failure. JAMA 294:334\u2013341","journal-title":"JAMA"},{"key":"1705_CR40","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2337\/diab.46.3.524","volume":"46","author":"M Bjornholm","year":"1997","unstructured":"Bjornholm M, Kawano Y, Lehtihet M, Zierath JR (1997) Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46:524\u2013527","journal-title":"Diabetes"},{"issue":"1","key":"1705_CR41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/eurheartj\/ehp396","volume":"31","author":"SA Cook","year":"2010","unstructured":"Cook SA, Varela-Carver A, Mongillo M et al (2010) Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J 31(1):100\u201311. https:\/\/doi.org\/10.1093\/eurheartj\/ehp396","journal-title":"Eur Heart J"},{"issue":"3","key":"1705_CR42","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1210\/jc.2009-1932","volume":"95","author":"AC Carpentier","year":"2010","unstructured":"Carpentier AC, Bourbonnais A, Frisch F, Giacca A, Lewis GF (2010) Plasma nonesterified fatty acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index. J Clin Endocrinol Metab 95(3):1256\u20131264. https:\/\/doi.org\/10.1210\/jc.2009-1932","journal-title":"J Clin Endocrinol Metab"},{"key":"1705_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1532-429X-15-103","volume":"15","author":"K Nyman","year":"2013","unstructured":"Nyman K, Gran\u00e9r M, Pentik\u00e4inen MO et al (2013) Cardiac steatosis and left ventricular function in men with metabolic syndrome. J Cardiovasc Magn Reson 15:103. https:\/\/doi.org\/10.1186\/1532-429X-15-103","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11","key":"1705_CR44","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1194\/jlr.P900032-JLR200","volume":"50","author":"R Marfella","year":"2009","unstructured":"Marfella R, Di Filippo C, Portoghese M et al (2009) Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J Lipid Res 50(11):2314\u201323. https:\/\/doi.org\/10.1194\/jlr.P900032-JLR200","journal-title":"J Lipid Res"},{"key":"1705_CR45","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","volume":"116","author":"JM McGavock","year":"2007","unstructured":"McGavock JM, Lingvay I, Zib I et al (2007) Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116:1170\u20131175","journal-title":"Circulation"},{"key":"1705_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/15592294.2016.1278097","volume":"12","author":"L Sommese","year":"2017","unstructured":"Sommese L, Zullo A, Mancini FP, Fabbricini R, Soricelli A, Napoli C (2017) Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus. Epigenetics 12:401\u2013415","journal-title":"Epigenetics"},{"key":"1705_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ehjcvp\/pvz062","volume":"6","author":"C Napoli","year":"2020","unstructured":"Napoli C, Benincasa G, Schiano C, Salvatore M (2020) Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients. Eur Heart J Cardiovasc Pharmacother 6:239\u2013247","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"1705_CR48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.amsu.2020.10.016","volume":"60","author":"G Benincasa","year":"2020","unstructured":"Benincasa G, Franzese M, Schiano C et al (2020) DNA methylation profiling of CD04+\/CD08+ T cells reveals pathogenic mechanisms in increasing hyperglycemia: PIRAMIDE pilot study. Ann Med Surg (Lond) 60:218\u2013226","journal-title":"Ann Med Surg (Lond)"},{"issue":"3 Pt 1","key":"1705_CR49","first-page":"E606","volume":"273","author":"D Giugliano","year":"1997","unstructured":"Giugliano D, Marfella R, Verrazzo G et al (1997) L-arginine for testing endothelium-dependent vascular functions in health and disease. Am J Physiol 273(3 Pt 1):E606-12","journal-title":"Am J Physiol"},{"key":"1705_CR50","doi-asserted-by":"publisher","first-page":"16489","DOI":"10.1096\/fj.202000860RR","volume":"34","author":"L Scisciola","year":"2020","unstructured":"Scisciola L, Rizzo MR, Cataldo V et al (2020) Incretin drugs effect on epigenetic machinery: new potential therapeutic implications in preventing vascular diabetic complications. FASEB J 34:16489\u201316503","journal-title":"FASEB J"},{"key":"1705_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/hh0102.102330","volume":"90","author":"LJ Ignarro","year":"2002","unstructured":"Ignarro LJ, Napoli C, Loscalzo J (2002) Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90:21\u201328","journal-title":"Circ Res"},{"key":"1705_CR52","doi-asserted-by":"publisher","first-page":"e207073","DOI":"10.1001\/jamacardio.2020.7073","volume":"20","author":"SB Dugani","year":"2021","unstructured":"Dugani SB, Moorthy MV, Li C et al (2021) Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiol 20:e207073. https:\/\/doi.org\/10.1001\/jamacardio.2020.7073","journal-title":"JAMA Cardiol"},{"key":"1705_CR53","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00125-012-2749-0","volume":"56","author":"ML Balestrieri","year":"2013","unstructured":"Balestrieri ML, Servillo L, Esposito A et al (2013) Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation. Diabetologia 56:162\u201372","journal-title":"Diabetologia"},{"key":"1705_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11010-020-03787-7","volume":"472","author":"R Messmann","year":"2020","unstructured":"Messmann R, Dietl A, Wagner S et al (2020) Alterations of the renin angiotensin system in human end-stage heart failure before and after mechanical cardiac unloading by LVAD support. Mol Cell Biochem 472:79\u201394","journal-title":"Mol Cell Biochem"},{"key":"1705_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2013.01.024","volume":"228","author":"R Menghini","year":"2013","unstructured":"Menghini R, Fiorentino L, Casagrande V, Lauro R, Federici M (2013) The role of ADAM17 in metabolic inflammation. Atherosclerosis 228:12\u201317","journal-title":"Atherosclerosis"},{"key":"1705_CR56","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1161\/CIRCULATIONAHA.111.050500","volume":"124","author":"D Carnevale","year":"2011","unstructured":"Carnevale D, Cifelli G, Mascio G et al (2011) Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3\/tumor necrosis factor-\u03b1-converting enzyme axis: crucial role for adaptive cardiac remodeling during cardiac pressure overload. Circulation 124:1337\u201350","journal-title":"Circulation"},{"key":"1705_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.105.571414","volume":"113","author":"PW Fedak","year":"2006","unstructured":"Fedak PW, Moravec CS, McCarthy PM et al (2006) Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. Circulation 113:238\u201345","journal-title":"Circulation"},{"issue":"1","key":"1705_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-021-01222-9","volume":"20","author":"P Paolisso","year":"2021","unstructured":"Paolisso P, Fo\u00e0 A, Bergamaschi L et al (2021) Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovasc Diabetol 20(1):33","journal-title":"Cardiovasc Diabetol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-021-01705-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T04:09:59Z","timestamp":1625890199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-021-01705-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1007\/s00592-021-01705-x","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not required for the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No infromed consent was required for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}